Ackermansiella muciniphila and application thereof in preparation of antioxidant products, anti-aging products or fat-reducing products

Through the application of AKK-PL001 strain of mucophilin, the problem of its insignificant effect in antioxidant, anti-aging and fat loss is solved, and the life span is significantly extended, mobility and reproductive ability are enhanced and fat is reduced. The accumulated effects demonstrate its significant effects in antioxidant, fat loss and anti-aging.

CN118909825APending Publication Date: 2024-11-08ZHEJIANG INST OF TIANJIN UNIV (SHAOXING)
View PDF 0 Cites 5 Cited by

Patent Information

Application Number
CN202410900729.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-05
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Akmania mucophilin has no significant effect in antioxidant, anti-aging and fat loss, and lacks effective applications and research.

Method used

Using Akkermansia muciniphila AKK-PL001 strain, the antioxidant capacity of C. elegans is enhanced by isolating, identifying and applying it to the preparation of antioxidant, anti-aging and fat-reducing products, and extending its lifespan and improving Motivation and reproductive ability to reduce fat accumulation.

Benefits of technology

The AKK-PL001 strain significantly extends the lifespan of nematodes, enhances its mobility and reproductive ability, reduces fat accumulation, improves antioxidant ability, and has significant antioxidant, fat loss and anti-aging effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909825A_ABST
    Figure CN118909825A_ABST
Patent Text Reader

Abstract

The invention discloses Akkermania muciniphila and application of the Akkermania muciniphila in preparation of an antioxidant product, an anti-aging product or a fat reducing product, and the Akkermania muciniphila AKK-PL001 CCTCC (China Center For Type Culture Collection) NO: M 2024483. The invention further discloses an application of the Akkermania muciniphila in preparation of the antioxidant product, the anti-aging product or the fat reducing product. Experiments prove that the Akkermansia muciniphila PL001 CCTCC M 2024483 disclosed by the invention can be used for enhancing the oxidation resistance of caenorhabditis elegans, prolonging the service life of the caenorhabditis elegans, improving the action power and the reproductive capacity of the caenorhabditis elegans, reducing fat accumulation and delaying the aging of an organism.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of probiotics. More specifically, it relates to Akkermansia muciniphila and its application in the preparation of antioxidant products, anti-aging products or fat-reducing products. Background Art

[0002] Aging is an inevitable law of the life process, and it is a process in which the functions of the body's tissues and organs undergo degenerative changes with age. The root cause of population aging is that aging leads to a decline in the health of the elderly population. The continued increase in the elderly population is bound to bring huge pressure on families and society to provide for the elderly. Current research shows that anti-aging can significantly improve the health of the elderly, delay the occurrence and development of geriatric diseases, reduce the various social needs of the elderly population, and fundamentally slow down the increase in social burdens caused by aging. It may become a fundamental measure to actively respond to population aging.

[0003] Studies have found that probiotics such as Lactobacillus plantarum, Lactiplantibacillus pentosus, Lactiplantibacillus coryniformis, Lactobacillus fermentans, Lactobacillus delbrueckii, and Leuconostoc lactis have antioxidant and fat-reducing effects, which can effectively prolong healthy life span and delay body aging. However, this effect has obvious strain specificity. Therefore, continuing to explore probiotic strains with antioxidant, fat-reducing, and anti-aging effects has broad and practical application value.

[0004] Akkermansia muciniphila (A.muciniphila) is a genus of Verrucomicrobia that exists in the human intestine and is the only human commensal bacterium in the phylum. It is a Gram-negative bacterium with an oval appearance and a filamentous structure composed of capsule polymers. It has pili but no flagella and spores. The bacterium colonizes in the mucus layer close to the intestinal mucosa and can grow under microaerobic conditions, which gives it an advantage when competing with other strict anaerobic bacteria in the intestine. In the past decade, A.muciniphila has received widespread attention due to its positive relationship with human health. The bacterium degrades mucin in the intestinal mucus layer, stimulates intestinal mucus renewal through positive feedback, and maintains the integrity of the intestinal mechanical barrier in humans and mice. In addition, A.muciniphila is also involved in regulating inflammatory immunity, maintaining the balance of microbiota, and coordinating host metabolism.

[0005] However, at present, the antioxidant, anti-aging and fat-reducing effects of Akkermansia muciniphila are not significant. Summary of the invention

[0006] The purpose of the present invention is to overcome the deficiencies of the prior art and provide Akkermansia muciniphila.

[0007] The second object of the present invention is to provide the use of the above-mentioned Akkermansia muciniphila in the preparation of antioxidant products.

[0008] The third object of the present invention is to provide the use of the above-mentioned Akkermansia muciniphila in the preparation of anti-aging products.

[0009] The fourth object of the present invention is to provide the use of the above-mentioned Akkermansia muciniphila in the preparation of fat-reducing products.

[0010] The technical solution of the present invention is summarized as follows:

[0011] Akkermansia muciniphila AKK-PL001 CCTCC NO: M2024483.

[0012] The application of the above-mentioned Akkermansia muciniphila in the preparation of antioxidant products.

[0013] The application of the above-mentioned Akkermansia muciniphila in the preparation of anti-aging products.

[0014] The use of the above-mentioned Akkermansia muciniphila in the preparation of fat-reducing products.

[0015] The present invention has the following beneficial effects:

[0016] Experiments have shown that the Akkermansia muciniphila PL001CCTCC M2024483 of the present invention can enhance the antioxidant capacity of Caenorhabditis elegans, prolong the life span of nematodes, improve the mobility and reproductive capacity of nematodes, reduce fat accumulation, and delay body aging. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 The effect of AKK-PL001 on the life span of C. elegans N2;

[0018] Figure 2 The changes in motility (A) and fertility (B) after feeding C. elegans with AKK-PL001;

[0019] Figure 3 To investigate the effect of feeding AKK-PL001 on the fat content of nematodes;

[0020] Figure 4The antioxidant properties of AKK-PL001 (A: MDA content; B: SOD activity; C: GSH content; D: CAT activity);

[0021] Figure 5 These are the ability curves of the components of AKK-PL001 bacteria to scavenge ORAC free radicals (A: fluorescence kinetic curve under different concentrations of Trolox; B: Trolox standard curve; C: fluorescence kinetic curve of the components of AKK-PL001 bacteria). DETAILED DESCRIPTION

[0022] Akkermansia muciniphila AKK-PL001 was deposited in the China Center for Type Culture Collection on March 14, 2024. The address of the collection is: Wuhan University, Wuhan, China. The collection number is CCTCCNO: M 2024483.

[0023] The present invention is further described below in conjunction with the accompanying drawings and specific examples, but the examples do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.

[0024] The reagents or formulations used in the following examples are:

[0025] NGM solid medium: 3g sodium chloride, 2.5g tryptone, 17g agar powder, 25mL potassium phosphate buffer (1mol / L), 1mL CaCl2 solution (1mol / L), 1mL MgSO4 solution (1mol / L), distilled water to 1000mL, autoclave at 121℃ for 20min. When the temperature drops to about 60℃, add 1mL cholesterol solution (5mg / mL, dissolved in 95% ethanol aqueous solution) under sterile conditions, shake well, and pour into a plate.

[0026] LB liquid medium: 5 g yeast powder, 10 g tryptone, 10 g NaCl, add distilled water to 1000 mL, and sterilize at 121°C for 20 min.

[0027] BHI liquid medium: BHI broth (38.5 g / L, manufacturer: Qingdao High-Tech Industrial Park Haibo Biotechnology Co., Ltd.), 0.4% mucin, 3 g / L threonine, 2.5 g / L N-acetyl-D-glucosamine, 0.05% L-cysteine ​​hydrochloride anhydrous.

[0028] BHI solid medium: Add 2% agar to BHI liquid medium.

[0029] Wild-type Caenorhabditis elegans N2 and Escherichia coli OP50 were purchased from Fujian Shangyuan Bioscience and Technology Co., Ltd.

[0030] The kits for measuring malondialdehyde (MDA) content, glutathione (GSH) content and catalase (CAT) enzyme activity were purchased from Nanjing Jiancheng Biological, and the kit for measuring superoxide dismutase (SOD) enzyme activity was purchased from Beyotime Biological.

[0031] Example 1 Isolation and identification of strains

[0032] 1. Isolation of strains

[0033] Sterile oxygen-free saline was used to dilute the fecal sample of a 46-year-old female volunteer from Beijing, China, in a gradient dilution method to obtain a concentration gradient of 10 -1 to 10 -11 Take 10 -9 , 10 -10 , 10 -11 Three gradients of bacterial solution were applied to the plate (BHI solid medium), and after evenly applied, the plate was inverted and placed in an anaerobic culture bag for culture. The strain growth time is about 72h to 120h. Single colonies suspected of Akkermansia muciniphila and Akk bacteria were selected and isolated from the colonies, and transferred to a new culture medium (BHI solid medium) by streaking to continue culture. Pick the slightly transparent, tiny single colonies that grew, use a 10μL pipette tip to gently scratch the surface of the colony, blow evenly in 10μL pure water to get the bacterial solution, and take 3μL for PCR amplification.

[0034] 2. Molecular Biology Identification

[0035] (1) Take 3 μL of the bacterial solution obtained in step 1 and prepare the PCR amplification system and run the program according to the following system for PCR amplification (see Tables 1 and 2).

[0036] Table 1: PCR reaction system

[0037]

[0038] Table 2: PCR reaction program

[0039]

[0040] SEQ ID NO.1 (upstream primer): 27f (5′-AGAGTTTGATCCTGGCTCAG-3′)

[0041] SEQ ID NO.2 (downstream primer): Nucleotide sequence listed: 1492r (5′-TACGGTTACCTTGTTACGACTT-3′)

[0042] (2) Prepare 1.5% agarose gel and add 10 μL Ultra GelRed (10000×) nucleic acid dye per 100 mL.

[0043] (3) Add 5 μL of the above PCR reaction solution to each well and use DL2000 marker as a band size control. The band size is about 327 bp, which can be preliminarily determined to be AKK bacteria.

[0044] (4) The samples preliminarily identified as AKK bacteria were further amplified by PCR using universal primers (SEQ ID NO.1, SEQ ID NO.2). The amplified PCR liquid was sent to Qingke Biotechnology Co., Ltd. for sequencing. After the sequencing results were obtained, the sequences were compared on the website https: / / blast.ncbi.nlm.nih.gov / Blast.cgi to obtain the comparison results.

[0045] (5) After comparison, the samples identified as AKK bacteria were expanded and cultured using BHI liquid medium for 72 hours. 100 μL of bacterial solution was taken for PCR amplification again. After amplification, it was sent to Qingke Biotechnology for sequencing, and the remaining bacterial solution continued to be cultured. After secondary sequencing, if it was identified as a single-peak AKK bacteria, it was pure AKK bacteria. The bacterial solution was centrifuged, the supernatant was poured out, and the cryopreservation protection solution was added (the volume ratio of the two was 1:1), and the solution was divided and stored in a -80℃ refrigerator. For whole genome sequencing, the AKK bacterial mud frozen in liquid nitrogen was sent to Genewise for sequencing. The sequencing results showed that the ANI analysis similarity between AKK-PL001 and AKK835 was 98.85%, which was Akkermansia muciniphila AKK-PL001; it was preserved in the China Center for Type Culture Collection.

[0046] Example 2 Tolerability Evaluation of AKK-PL001

[0047] Akkermansia muciniphila PL001 CCTCC NO: M2024483, abbreviated as AKK-PL001.

[0048] 1. Evaluation of acid tolerance performance of AKK-PL001

[0049] (1) Test method

[0050] The frozen AKK-PL001 was inoculated into BHI liquid culture medium at 1% inoculation and cultured anaerobically in an incubator at 37°C. After 3 days of culture, the bacterial solution was transferred to fresh BHI liquid culture medium at 5% inoculation and cultured anaerobically in an incubator at 37°C. After 60-72 hours of culture, 5 ml of bacterial solution was collected under sterile conditions and centrifuged at 8000rpm for 5 minutes to separate the bacteria. The bacterial precipitate was resuspended with physiological saline and mixed thoroughly, and the bacteria were collected by centrifugation at 8000rpm for 5 minutes. The bacteria were resuspended and mixed thoroughly with equal volumes of BHI liquid culture medium with pH=2 and pH=3, respectively, and then incubated in an anaerobic environment at 37°C. Take the bacterial solution incubated for 0h, 1.5h and 3h, and dilute the bacterial solution 10 times with physiological saline, select the appropriate dilution (selected by strain growth) for plating (BHI solid culture medium). Select 2 dilutions for each sample, and make 2 plates for each dilution. The coated plate was inverted and placed in a 37°C incubator for anaerobic culture. After 3-5 days of culture, the growth status of the colonies on the plate was observed, the number of colonies was recorded, and the survival rate was calculated.

[0051]

[0052] A0 is the number of colonies after incubation for 0 hours, and An is the number of colonies after incubation for n hours.

[0053] (2) Test results

[0054] The survival of AKK-PL001 in acidic environment is shown in Table 3.

[0055] Table 3 Statistical table of acid tolerance of AKK-PL001

[0056]

[0057] 2. Evaluation of bile salt tolerance of AKK-PL001

[0058] (1) Test method

[0059] AKK-PL001 was resuspended and mixed with equal volumes of BHI liquid culture medium containing 0.3% and 1% mass concentration of bile salts, and then incubated at 37°C in an anaerobic environment. The bacterial solution was incubated for 0h, 4h and 8h, and the bacterial solution was diluted 10 times with physiological saline, and the appropriate dilution was selected for plating. Two dilutions were selected for each sample, and two plates were made for each dilution. The coated plates were inverted in a 37°C incubator for anaerobically cultured. After 3-5 days of culture, the growth status of the colonies on the plates was observed, the number of colonies was recorded, and the survival rate was calculated.

[0060]

[0061] A0 is the number of colonies after incubation for 0 hours, and An is the number of colonies after incubation for n hours.

[0062] (2) Test results

[0063] The survival of AKK-PL001 in a bile salt environment is shown in Table 4. Normally, the bile salt concentration in the human physiological environment does not exceed 0.3%.

[0064] Table 4 Statistical table of bile salt tolerance of AKK-PL001

[0065]

[0066] 3. Evaluation of AKK-PL001 artificial gastric juice tolerance

[0067] (1) Test method

[0068] AKK-PL001 was resuspended and mixed with equal volumes of artificial gastric juice at pH = 2 and pH = 3, and then incubated at 37°C in an anaerobic environment. The bacterial solution was incubated for 0h, 1.5h and 3h, and the bacterial solution was diluted 10 times with physiological saline, and the appropriate dilution was selected for plating. Two dilutions were selected for each sample, and two plates were made for each dilution. The coated plates were inverted in a 37°C incubator for anaerobically cultured. After 3-5 days of culture, the growth status of the colonies on the plates was observed, the number of colonies was recorded, and the survival rate was calculated.

[0069]

[0070] A0 is the number of colonies after incubation for 0 hours, and An is the number of colonies after incubation for n hours.

[0071] (2) Test results

[0072] The survival of AKK-PL001 in artificial gastric fluid is shown in Table 5.

[0073] Table 5 Statistical table of tolerance of AKK-PL001 to artificial gastric juice

[0074]

[0075] 4. Evaluation of AKK-PL001 artificial intestinal fluid tolerance

[0076] (1) Test method

[0077] Resuspend AKK-PL001 with equal volumes of artificial intestinal fluid and mix thoroughly, then incubate at 37°C in an anaerobic environment. Incubate the bacterial solution for 0h, 4h, and 8h, and dilute the bacterial solution 10 times with physiological saline, and select the appropriate dilution for plating. Select 2 dilutions for each sample, and make 2 plates for each dilution. The plate after plating is inverted in a 37°C incubator for anaerobically cultured. After 3-5 days of culture, observe the growth status of the colonies on the plate, record the number of colonies, and calculate the survival rate.

[0078]

[0079] A0 is the number of colonies after incubation for 0 hours, and An is the number of colonies after incubation for n hours.

[0080] (2) Test results

[0081] The survival of AKK-PL001 and standard strains in artificial intestinal fluid is shown in Table 6.

[0082] Table 6 Statistical table of tolerance to artificial intestinal fluid of AKK-PL001

[0083]

[0084] Example 3 Lifespan test of wild-type Caenorhabditis elegans N2 (hereinafter referred to as nematode) by AKK-PL001

[0085] 1. Activation of bacteria

[0086] Take 200 μL of AKK-PL001 frozen at -80°C, inoculate it into 10 mL of BHI liquid culture medium, put it into an anaerobic bag, and culture it anaerobically at 37°C for 48 to 72 hours to activate the strain.

[0087] 2. Cultivation of nematodes

[0088] E. coli OP50 (OD=0.5) was spread on NGM solid culture medium as nematode food, and then the nematodes were picked and placed on the surface of NGM solid culture medium, and cultured in a 20°C biochemical incubator. During the culture period, the nematodes needed to be transferred to a fresh NGM plate coated with E. coli OP50 every other day.

[0089] 3. Synchronization of nematodes

[0090] Collect L4 nematodes into a centrifuge tube, add 1 mL of M9 buffer to wash away excess E. coli OP50, remove the supernatant after settling, and repeat the wash 3 times. Then add 1 mL of lysis buffer and shake thoroughly, remove the supernatant, and then centrifuge (3000r / min, 1min) with M9 buffer to wash 3 times, remove the supernatant and retain the eggs, transfer the eggs to a new NGM plate, and incubate in a 20°C biochemical incubator. After about 16 to 18 hours, they will grow into L1 larvae.

[0091] 4. Determination of nematode lifespan

[0092] AKK-PL001 and Escherichia coli OP50 were cultured in LB liquid culture medium to the logarithmic phase, centrifuged at 4°C, 8000r / min for 10min, and AKK-PL001 cells were collected as food. The cells fed only with Escherichia coli OP50 were used as a control, and the nematodes were fed separately and their lifespans were measured.

[0093] 90 L1 larvae synchronized in the above steps were selected and placed on NGM plates containing AKK-PL001 and E. coli OP50, respectively, and cultured in a 20°C biochemical incubator. All surviving nematodes were selected and transferred to fresh NGM plates coated with bacterial solution every other day to prevent newly hatched nematodes from affecting the experimental results. The experiment continued until all nematodes died, and the nematode lifespan curve was drawn.

[0094] 5. Test results

[0095] The results are as follows Figure 1 As shown, compared with the average lifespan (12d) and the maximum lifespan (20d) of the nematodes fed with E. coli OP50, the average lifespan of AKK-PL001 was significantly extended by 38.8% (p<0.05), and the maximum lifespan was extended by 10 days, indicating that AKK-PL001 can significantly extend the lifespan of nematodes.

[0096] Example 4 Effect of AKK-PL001 on Nematode Motility and Fertility

[0097] 1. Test methods

[0098] (1) Exercise ability is one of the key indicators of health. Exercise status and exercise ability will gradually deteriorate and weaken with the aging of the body. The AKK-PL001 strain was used to culture nematodes. The culture method was the same as in Example 3. Only Escherichia coli OP50 was fed as the control group. On the third day, 20 nematodes were randomly selected and placed on a fresh NGM plate. After the nematodes moved freely for 30 seconds, the frequency of the nematode body bending and swinging within 20 seconds was observed using a stereo microscope. One body bending refers to the body bending from one direction to another and then returning to the original direction.

[0099] (2) The anti-aging drugs or strains to be screened should not damage the reproductive capacity of the body as a prerequisite. Reproductive capacity is one of the most critical indicators of health. Therefore, the effect of AKK-PL001 on the reproductive capacity of nematodes was verified using the number of offspring as an indicator. According to the method described in Example 3, the nematodes were cultured with the strain to be tested until the L4 stage, and one nematode was randomly selected and placed on an NGM plate coated with AKK-PL001 and Escherichia coli OP50, with 5 parallels in each group. During the nematode egg-laying period, the egg-laying adults were transferred to a new plate every 1 day, and the old plate continued to be placed in a 20°C biochemical incubator until the eggs hatched, and the total number of hatched larvae on the plate was counted until the nematode eggs were hatched.

[0100] 2. Experimental results

[0101] Compared with the E. coli OP50 control group, the body bending and swinging frequency of nematodes in the AKK-PL001 group increased by 41.1% and 36.9% on the 3rd and 12th days, respectively. Figure 2 A, p < 0.05), the total egg laying increased by 41.5% ( Figure 2 B, p<0.05). This indicates that feeding AKK-PL001 can significantly enhance the mobility and reproductive capacity of nematodes and has good anti-aging properties.

[0102] Example 5 Effect of AKK-PL001 on the fat content of nematodes

[0103] 1. Test methods

[0104] AKK-PL001 was used to culture nematodes, and the culture method was the same as in Example 3. Escherichia coli OP50 was fed as a control group. After continuing to culture for 3 days in the L4 stage, 20 nematodes were randomly selected to measure the nematode fat by red oil O staining. The nematodes were rinsed 3 times with M9 buffer, the throat was sealed with 25mM levamisole hydrochloride, 200μL of 4% paraformaldehyde solution was added and allowed to stand for 20min, the solution was removed and then frozen and thawed with liquid nitrogen 3 times, and then stained with 60% isopropanol red oil O. After 5h, the excess dye was rinsed with M9 buffer and observed with an optical microscope.

[0105] 2. Test results

[0106] Compared with the E. coli OP50 control group, the fat content of nematodes fed with AKK-PL001 was significantly reduced ( Figure 3 A). Image J software was used to analyze the red light optical density of fat, and it was found that the red light optical density of nematode fat was significantly reduced after AKK-PL001 intervention, decreasing by 34.8% ( Figure 3 B, p<0.05). This indicates that AKK-PL001 significantly reduces fat deposition in nematodes, thereby affecting nematode fat metabolism.

[0107] Example 6 Effect of AKK-PL001 on the Antioxidant Capacity of Nematodes

[0108] 1. Test methods

[0109] The AKK-PL001 strain was used to culture nematodes. The culture method was the same as in Example 3. Only Escherichia coli OP50 was fed as the control group. After continuing to culture for 3 days in the L4 stage, the nematodes were collected and washed with M9 buffer 3 times, and then the nematodes were allowed to settle naturally. The nematodes were placed in a homogenizer, ground on ice, and centrifuged at 4°C, 4000r / min to obtain the supernatant, which was the protein homogenate. The malondialdehyde (MDA) content, superoxide dismutase (SOD) enzyme activity, glutathione (GSH) content, and catalase (CAT) enzyme activity were measured according to the operating instructions of the kit.

[0110] 2. Test results

[0111] Compared with the control group of E. coli OP50, the MDA content in nematodes fed with AKK-PL001 was significantly reduced by 32.1% ( Figure 4 A, p<0.05), SOD activity was significantly increased by 89.1% ( Figure 4 B, p<0.05), GSH content increased significantly by 92.6% ( Figure 4 C, p<0.05, CAT activity increased significantly by 51.5% ( Figure 4 D, p<0.05). The above results indicate that AKK-PL001 can enhance the antioxidant capacity of nematodes by increasing SOD enzyme activity, CAT enzyme activity and GSH content and reducing MDA content in the body.

[0112] Example 7 Scavenging effect of each component of AKK-PL001 on ORAC free radicals

[0113] 1. Test methods

[0114] The antioxidant capacity index (oxygen radical absorbance capacity, ORAC) is a commonly used method for determining antioxidant capacity. By this method, the in vitro antioxidant capacity of the supernatant, live bacteria, pasteurized, and lysed components of the AKK-PL001 strain was determined. The specific method is: add 25μL of Trolox, 25μL of sample, and 150μL of FL fluorescent agent to a 96-well plate, place it in a microplate reader and incubate it at 37°C in the dark for 15 minutes, then add 25μL of APH, use phosphate buffer (phosphate buffer prepared with disodium hydrogen phosphate dodecahydrate and sodium dihydrogen phosphate dihydrate) as a control, and set up yin and yang controls at the same time;

[0115] Negative control: 175 μL phosphate buffer (phosphate buffer prepared from disodium hydrogen phosphate dodecahydrate and sodium dihydrogen phosphate dihydrate) plus 25 μL APH.

[0116] Positive control: 50 μL phosphate buffer (phosphate buffer prepared from disodium hydrogen phosphate dodecahydrate and sodium dihydrogen phosphate dihydrate) plus 150 μL FL fluorescent agent).

[0117] The fluorescence intensity was measured at an excitation wavelength of 485 nm and an emission wavelength of 525 nm, and the reading was taken every 10 minutes until the fluorescence decayed to the baseline. The larger the ORAC value, the stronger the oxygen free radical absorption capacity of the AKK-PL001 strain, and the higher its antioxidant activity. Note: In this experiment, the supernatant was diluted 1000 times, and the live bacteria, pasteurized, and lysed were all diluted 10 times.

[0118] 2. Test results

[0119] The AUC values ​​of Trolox at concentrations of 100, 25, 12.5, 6.25, 3.125, and 0 μM were determined according to the above method. The AUC value was used as the ordinate and the concentration of Trolox (μM) was used as the abscissa to obtain the standard curve and linear equation established by the area under the fluorescence kinetic curve of Trolox at different concentrations and the Trolox concentration. After fitting, the standard curve equation of Trolox was obtained as follows: Y=1.5X+39.4, and the linear correlation coefficient R 2 =0.993, indicating that the standard curve has a high correlation. Where X is the concentration of Trolox, and Y is the AUC value. The obtained standard curve is as follows Figure 5 AB.

[0120] Figure 5 C is the fluorescence kinetic curve of each component of AKK-PL001 bacteria. Table 7 shows the ORAC value of each component of AKK-PL001 bacteria. It can be seen that among the four components of supernatant, live bacteria, pasteurized, and lysed, the ORAC value of the supernatant is the largest, reaching 1.29×10 6 μMTrolox, the ORAC value of live bacteria is 1.1×10 3 μM Trolox, the ORAC value of pasteurized is 1.24×10 3 μM Trolox, the ORAC value of lysis was 1.45×10 3 μM Trolox. This indicates that the supernatant of AKK-PL001 bacteria has the strongest antioxidant activity, followed by lysis, pasteurization, and live bacteria.

[0121] Table 7 Ability of each component of AKK-PL001 bacteria to scavenge ORAC free radicals

[0122]

[0123] In summary, the AKK-PL001 strain provided by the present invention can prolong the life span of nematodes, enhance mobility and reproductive ability, reduce fat accumulation, increase the production of SOD, GSH, CAT, etc. and reduce the MDA content in the body, has the effects of anti-oxidation, fat reduction and anti-aging, and is a probiotic.

[0124] The product is a health food, medicine, feed or additive, and its preparation form is liquid, jelly, stick, powder, tablet, granule or capsule.

[0125] The embodiments of the present invention are described in detail above, but the present invention is not limited to the described embodiments. For those skilled in the art, various changes, modifications, substitutions and variations of these embodiments are made without departing from the principles and spirit of the present invention, and still fall within the protection scope of the present invention.

Claims

1. Akkermansia muciniphila AKK-PL001 CCTCC NO: M 2024483.

2. Use of Akkermansia muciniphila according to claim 1 in the preparation of antioxidant products.

3. Use of Akkermansia muciniphila according to claim 1 in the preparation of anti-aging products.

4. Use of Akkermansia muciniphila according to claim 1 in the preparation of fat-reducing products.

Citation Information

Cited By

  • Isolated ackermansiella muciniphila, composition comprising same and anti-aging and / or anti-oxidation use thereof

    CN119842568A

  • Luciphil Ackermann strain and application thereof in preparation of anti-weakness or healthy life prolonging product

    CN120683002A

  • Application of isolated ackermansiella muciniphila in resisting brain aging and nerve cell or nervous system aging

    CN121466139A

  • Akkermansia muciniphila, and use thereof in preparation of antioxidant product, Anti-aging product or fat reduction product

    WO2025236973A1

  • Akkermansia muciniphila strains DSM 35203 and DSM 35204 for use in preventing and / or delaying aging and conditions related thereto

    WO2026120472A1